Literature DB >> 8578189

Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).

C Qualmann1, M A Nauck, J J Holst, C Orskov, W Creutzfeldt.   

Abstract

BACKGROUND: After nutrient ingestion there is an early response of glucagon-like peptide 1 (GLP-1) immunoreactivity, although GLP-1 is mainly produced in endocrine cells from the lower gut (ileum and colon/rectum), suggesting that indirect stimulation is important after the ingestion of carbohydrates that are predominantly absorbed from the upper intestine.
METHODS: To enable contact of sucrose with lower gut mucosa, sucrose was administered by mouth with and without the simultaneous ingestion of 100 mg of the alpha-glucosidase inhibitor acarbose to six normal healthy volunteers.
RESULTS: There was an early increment in GLP-1 15 min after sucrose ingestion. With acarbose, sucrose reached the colon approximately 120 min after ingestion, as indicated by an increment in breath hydrogen exhalation (p < 0.0001), and GLP-1 release was prolonged (p < 0.0001). The sucrose-related increments in glucose, insulin, C-peptide, and gastric inhibitory polypeptide (GIP) and the suppression of glucagon were only marginally affected by acarbose administration.
CONCLUSIONS: GLP-1 release appears to be influenced by indirect mechanisms (early response after sucrose) and by direct luminal contact with lower gut mucosal endocrine cells (late response with acarbose).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578189     DOI: 10.3109/00365529509101597

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  42 in total

1.  Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms.

Authors:  Jingchuan Zhang; Robert C Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

2.  [Hormonal and metabolic functions of the small intestine].

Authors:  H Wittenburg; U Tennert; J Mössner
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

Review 3.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

4.  Uncoupling protein 2 regulates glucagon-like peptide-1 secretion in L-cells.

Authors:  Yan Chen; Zheng-Yang Li; Yan Yang; Hong-Jie Zhang
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

5.  Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.

Authors:  Wendell J Lu; Qing Yang; Li Yang; Dana Lee; David D'Alessio; Patrick Tso
Journal:  Lipids       Date:  2012-06       Impact factor: 1.880

Review 6.  Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms.

Authors:  Richard D Mattes; Barry M Popkin
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

7.  Hypoglycemic and hypolipidemic effects of Saururus chinensis Baill in streptozotocin-induced diabetic rats.

Authors:  Ji-Yeon Hwang; Jian Zhang; Min-Jung Kang; Soo-Kyung Lee; Hyun-A Kim; Jong-Jin Kim; Jung-In Kim
Journal:  Nutr Res Pract       Date:  2007-06-30       Impact factor: 1.926

8.  [Continuous blood glucose monitoring: the acute effect of acarbose on blood glucose variations].

Authors:  B L Herrmann; H Schatz; A Pfeiffer
Journal:  Med Klin (Munich)       Date:  1998-11-15

Review 9.  Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

Authors:  André J Scheen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  The environment within: how gut microbiota may influence metabolism and body composition.

Authors:  A Vrieze; F Holleman; E G Zoetendal; W M de Vos; J B L Hoekstra; M Nieuwdorp
Journal:  Diabetologia       Date:  2010-01-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.